Cibus, Inc. Class A Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CBUS Company Description
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
CBUS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CBUS Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CBUS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CBUS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CBUS in WallStreetBets Daily Discussion
CBUS News
Recent insights relating to CBUS
CNBC Recommendations
Recent picks made for CBUS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CBUS
Corporate Flights
Flights by private jets registered to CBUS
Our Analysis